Thalamic volume in pediatric obsessive-compulsive disorder patients before and after cognitive behavioral therapy

Biological Psychiatry

Volumn 48, Issue 4, 2000, Pages 294-300

  Rosenberg, David R ^a   Benazon, Nili R ^a   Gilbert, Andrew ^b   Sullivan, April ^a   Moore, Gregory J ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Cognitive behavioral therapy; Magnetic resonance imaging; Obsessive compulsive disorder; Pediatric; Thalamus

Indexed keywords

PAROXETINE;

ADOLESCENT; ARTICLE; BEHAVIOR THERAPY; BRAIN FUNCTION; CHILD; CLINICAL ARTICLE; COGNITIVE THERAPY; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSESSION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; THALAMUS; TREATMENT OUTCOME;

ADOLESCENT; CHILD; COGNITIVE THERAPY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; OBSESSIVE-COMPULSIVE DISORDER; THALAMUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0034663346     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(00)00902-1     Document Type: Article

References (47)

1. Ammons R.B., Ammons C.H. Ammons Quick I.Q. Test. 1962;Psychological Test Specialists, Missoula, MT.
2. Andreason NC, Arndt S, Swayze V, Cizadlo T, Flaum M, O'Leary D, et al (1994): Thalamic abnormalities in schizophrenics visualized through magnetic resonance imaging. Science 266(5183):294-298.
3. Bartha R., Stein M.B., Williamson P.C., Drost D.J., Neufield R.W., Carr T.J., et al. A short echo 1H spectroscopy and volumetric MRI study of the corpus striatum in patients with obsessive compulsive disorder and comparison subjects. Am J Psychiatry. 155:1998;1584-1591.
4. Baxter L.R. Neuroimaging studies of obsessive-compulsive disorders. Psychiatr Clin North Am. 15:1992;871-884.
5. Baxter L.R., Saxena S., Brody A.L., Ackermann R.F., Colgan M., Schwartz J.M., et al. Brain mediation of obsessive-compulsive disorder symptoms Evidence from functional brain imaging studies in the human and nonhuman primate . Semin Clin Neuropsychiatry. 1:1996;32-47.
6. Bennett-Clarke C.A., Chiaia N.L., Rhoades R.W. Thalamocortical afferents in rat transiently express high-affinity serotonin uptake sites. Brain Res. 733:1996;301-306.
7. Bennett-Clarke C.A., Lane R.D., Rhoades R.W. Fenfluramine depletes serotonin from the developing cortex and alters thalamocortical organization. Brain Res. 702:1995;255-260.
8. Breiter H.C., Rauch S.L., Kwong K.K., Baker J.R., Weiskoff R.M., Kennedy D., et al. Functional magnetic resonance imaging of symptom provication in obsessive compulsive disorder. Arch Gen Psychiatry. 53:1996;595-606.
9. Buchsbaum M.S., Someya T., Teng C.Y., Abel L., Chin S., Najafi A., et al. PET and MRI of the thalamus in never-medicated patients with schizophrenia. Am J Psychiatry. 153:1996;191-199.
10. Chakos M.H., Lieberman J.A., Bilder R.M. Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. Am J Psychiatry. 151:1994;1430-1436.
11. Chiocca EA, Martuza RL (1990): Neurosurgical therapy of obsessive compulsive disorder. In: Jenike MA, Baer L, Minichiello WE, editors. Chicago: Year Book Medical Publishing.
12. Chubakov A.R., Gromova E.A., Konovalov G.V., Sarkisova E.F., Chumasov E.I. The effect of serotonin on the morpho-functional development of rat cerebral neocortex in tissue culture. Brain Res. 369:1986;285-297.
13. Chugani D.C., Muzik O., Chakraborty P., Mangner T., Chugani H.T. Human brain serotonin synthesis capacity measured in vivo with alpha-[C-11] methyl-L-tryptophan. Synapse. 28:1998;33-43.
14. Cottraux J., Gerard D., Cinotti L., Froment J.C., Deiber M.P., Le Bars D., et al. A controlled positron emission tomography study of obsessive and neutral auditory stimulation in obsessive-compulsive disorder with checking rituals. Psychiatry Res. 60:1996;101-112.
15. Fitzgerald K.D., Moore G.J., Paulson L.D., Stewart C.M., Rosenberg D.R. Proton spectroscopic imaging of the thalamus in treatment-naive pediatric obsessive-compulsive disorder. Biol Psychiatry. 47:2000;174-182.
16. Flament M.F., Whitaker A., Rapoport J.L. Obsessive compulsive disorder in adolescence An epidemiological study . J Am Acad Child Adolesc Psychiatry. 27:1988;764-771.
17. Gilbert AR, Moore GJ, Keshavan MS, Paulson LD, Narula V, MacMaster FP, et al (2000): Decrease in thalamic volumes of pediatric patients with obsessive-compulsive disorder who are taking paroxetine. Arch Gen Psychiatry 57:449-456.
18. Grados M., Scahill L., Riddle M.A. Pharmacotherapy in children and adolescents with obsessive-compulsive disorder. Child Adolesc Psychiatr Clin North Am. 8:1999;617-634.
19. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 32:1959;50-55.
20. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 6:1967;278-296.
21. Hanna G.L. Demographic and clinical features of obsessive-compulsive disorder in children and adolescents. J Am Acad Child Adolesc Psychiatry. 34:1995;19-27.
22. Hollingshead A. Four Factor Index of Social Status. 1978;Yale University, Department of Sociology, New Haven, CT.
23. Insel T.R. Toward a neuroanatomy of obsessive-compulsive disorder. Arch Gen Psychiatry. 49:1992;739-744.
24. Kaufman J., Birmaher B., Brent D., Rao U., Flynn C., Moreci P., et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children - Present and Lifetime Version (K-SADS-PL) Initial reliability and validity data . J Am Acad Child Adolesc Psychiatry. 36:1997;980-988.
25. Keshavan M.S., Bagwell W.W., Haas G.L., Sweeney J.A., Schooler N., Pettegrew J.W. Changes in caudate volume with neuroleptic treatment. Lancet. 344:1994;1434.
26. Knights R.M., Norwood J. Revised Smoothed Normative Data on the Neuropsychological Test Battery for Children. 1980;Carleton University, Ottawa.
27. Lebrand C., Cases O., Adelbrecht C., Doye A., Alvarez C., El Mestikawy S., et al. Transient uptake and storage of serotonin in developing thalamic neurons. Neuron. 17:1996;823-835.
28. Leckman J.F., Riddle M.A., Hardin M.T., Ort S.I., Swartz K.L., Stevenson J., et al. The Yale Global Tic Severity Scale Initial testing of a clinician-rated scale of tic severity . J Am Acad Child Adolesc Psychiatry. 28:1989;566.
29. Lucey J.V., Costa D.C., Blanes T., Busatto G.F., Pilowsky L.S., Takei N., et al. Regional cerebral blood flow in obsessive-compulsive disordered patients at rest. Differential correlates with obsessive-compulsive and anxious-avoidant dimensions. Br J Psychiatry. 167:1995;629-634.
30. March J.S., Mulle K. OCD in Children and Adolescents A Cognitive Behavioral Treatment Manual . 1998;Guilford, New York.
31. McGuire P.K., Bench C.J., Frith C., Marks I.M., Frackowiak R.S., Dolan R.J. Functional anatomy of obsessive-compulsive phenomena. Br J Psychiatry. 164:1994;459-468.
32. Modell J.G., Mountz J.M., Curtis G.C., Greden J.F. Neurophysiologic dysfunction in basal ganglia/limbic striatal and thalamocortical circuits as a pathogenetic mechanism of obsessive-compulsive disorder. J Neuropsychiatry. 1:1989;27-36.
33. Oke A.F., Carver L.A., Gouvion C.M., Adams R.N. Three-dimensional mapping of norepinephrine and serotonin in human thalamus. Brain Res. 763:1997;69-78.
34. Pakkenberg B. The volume of the mediodorsal thalamic nucleus in treated and untreated schizophrenics. Schizophr Res. 7:1992;95-100.
35. Pauls D.L., Alsobrook J.P. II, Phil M., Goodman W., Rasmussen S., Leckman J.F. A family study of obsessive-compulsive disorder. Am J Psychiatry. 152:1995;76-84.
36. 18F] FDG PET study in obsessive-compulsive disorder A clinical/metabolic correlation study after treatment . Br J Psychiatry. 166:1995;244-250.
37. Portas C.M., Goldstein J.M., Shenton M.E., Hokama H.H., Wible C.G., Fischer I., et al. Volumetric evaluation of the thalamus in schizophrenic male patients using magnetic resonance imaging. Biol Psychiatry. 43:1998;649-659.
38. Rauch S.L., Jenike M.A., Alpert N.M., Breiter H.C.R., Savage C.R., Fischman A.J. Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch Gen Psychiatry. 51:1994;62-70.
39. Rhoades R.W., Bennett-Clarke C.A., Shi M.Y., Mooney R.D. Effects of 5-HT on thalamacortical synaptic transmission in the developing rat. J Neurophysiol. 72:1994;2438-2450.
40. Rosenberg D.R., Keshavan M.S. Toward a neurodevelopmental model of obsessive compulsive disorder. Biol Psychiatry. 43:1998;623-640.
41. Rosenberg D.R., Keshavan M.S., O'Hearn K.M., Dick E.L., Bagwell W.W., Seymor A.B., et al. Fronto-striatal measurement of treatment-naive pediatric obessive compulsive disorder. Arch Gen Psychiatry. 54:1997;824-830.
42. Salt T.E., Eaton S.A. Functions of ionotropic and metabotropic glutamate receptors in sensory transmission in the mammalian thalamus. Prog Neurobiol. 48:1996;55-72.
43. Scahill L., Riddle M.A., McSwiggin-Hardin M., Ort S.I., King R.A., Goodman W.K., et al. Children's Yale-Brown Obsessive Compulsive Scale Reliability and validity . J Am Acad Child Adolesc Psychiatry. 36:1997;844-852.
44. Schwartz J.M., Stoessel P.W., Baxter L.R., Martin K.M., Phelps M.E. Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. Arch Gen Psychiatry. 53:1996;109-113.
45. Staal W.G., Hulshoff Pol H.E., Schnack H., van der Schot A.C., Kahn R.S. Partial volume decrease of the thalamus in relatives of patients with schizophrenia. Am J Psychiatry. 155:1998;1784-1786.
46. Valleni-Basile L.A., Garrison C.Z., Jackson K.L., Waller J.L., McKeown R.E., Addy C.L., et al. Frequency of obsessive-compulsive disorder in a community sample of young adolescents. J Am Acad Child Adolesc Psychiatry. 33:1994;782-791.
47. Wechsler D. Wechsler Intelligence Scale for Children. 1991;Psychological Corp, New York.